Paraneoplastic Cerebellar Degeneration with Anti-Yo Antibodies - A Review
Ann Clin Trans Neurol 3:655-663, Venkatraman,A. & Opal,P., 2016
Intracranial Neoplasms and Paraneoplastic Disorders, Carcinomatous Meningitis
Adams & Victors Principles of Neurology, Chp 31, pg 662, Ropper, A.H.,et al, 2014
Clinicopath Conf., Paraneoplastic Cerebellar Degeneration Due to Anti-Yo Antibodies From Breast Cancer
NEJM 356:612-620, Case 4-2007, 2007
Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999
Twelfth-Nerve Palsy:Analysis of 100 Cases
Arch Neurol 53:561-566, Keane,J.R., 1996
Neuroimaging and Cerebrospinal Fluid Cytology in the Diagnosis of Leptomeningeal Metastasis
Ann Neurol 38:51-57, Frelich,R.J.,et al, 1995
Numb Chin Syndrome in Cancer Patients:Etiology, Response to Treatment, and Prognostic Significance
Neurol 42:1181-1184, Lossos,A.&Seigal,T., 1992
Cranial Neuropathy in Systemic Malignancy in a VA Population
Neurol 40:997-999, Gupta,S.R.,et al, 1990
Clinicopath Conf
Adenocarcinoma of Lung, with Metastasis to Meninges of Brain, Spinal Cord & Optic Nerves, Case Recor, 14-1EJM 318:903-915,1988., 1988
Neurological Involvement in the Epidermal Naevus Syndrome
JNNP 41:466, McAuley,D.L.,et al, 1978
Case Records of the MGH
Aquamous-cell CA of Cerebellopontine Angle, NEJM 296:2711977., , 1977
Central Pontine Myelinolysis
Quart J Med 45:373, Tomlinson,B.E.,et al, 1976
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
Brain CT for Diagnosis of Intracranial Disease in Ambulatory Patients with Cancer:Assessment of the Diagnostic Value of Scanning without Contrast Prior to With Contrast
AJNR 47:694-698, Wang,E.,et al, 2026
Creutzfeldt-Jakob-Like Presentation in Anti-AMPAR Encephalitis
Ann Neurol 99:1466-1467, Durbano,K.et al, 2026
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults with Cancer
Neurol 105:e214325, Balali,P.,et al, 2025
Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Stroke 55:1416-1427, Tartarin,H.,et al, 2024
Association of Acute Incidental Cerebral Microinfarcts with Subsequent Ischemic Stroke in Patients wth Cancer
Neurol 103: e209555, Naftali,J.,et al, 2024
Tumbolism, Acute Cerebral Occlusion Due to Carcinoma Embolus
Neurol 103:e209880, Jafri,N.,et al, 2024
Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
JAMA Neurol 81:957-965, Navi,B.B.,et al, 2024
Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome, A Systematic Review
Neurol 103:e209844, Dhawan,A.,et al, 2024
Diagnosis of Incident Cancer After Cryptogenic Stroke
Neurol 103:e210027, Navi,B.B.,et al, 2024
Clinicopathologic Conference, Paraneoplastic Vasculitis of the Central Nervous System
NEJM 388:747-757, Case 6-2023, 2023
An 82-Year-Old Woman with Subacute Ophthalmoparesis and Ataxia
Neurol 101:e570-e575, Rodrigo-Gisbert,M.,et al, 2023
Perioperative Acute Ischemic Stroke in Patients with Atrial Fibrillation
Ann Neurol 94:321-329, Shu,L.et al, 2023
Cutaneous Lesions and Leptomeningeal Carcinomatosis in Gastric Signet-Ring Cell Carcinoma
Neufol 101:e1104-e1105, Silverman,A.,et al, 2023
Risk and Prognosis of Cancer in Patients with Cerebral Venous Thrombosis Compared with the Danish General Population
Stroke 54:2576-2582, Skajaa,N.,et al, 2023
Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023
Progressive Cranial Neuropathy
JAMA Neurol 80:1375-1376, Buchberger,D.S.,et al, 2023
A 67-Year-Old Woman with Progressive Diplopia, Vertigo, and Ataxia
Neurol 98:e669-e674, Sakoda, M.,et al, 2022
MR Three-Territory Sign in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome)
Neurologist 27:37-40, Finelli, P.F., 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
Investigating Outcomes Post-Endovascular Thrombectomy in Acute Stroke Patients with Cancer
Neurol 99:e2583-e2592, Shapiro,S.D.,et al, 2022
Clinicopathologic Conference, Disseminated Mycobacterium Bovis Infection
NEJM 384:651-662, Case 5-2021, 2021
Cancer and Embolic Stroke of Undetermined Source
Stroke 52:1121-1130, Navi,B.B.,et al, 2021
Immediate and Long-Term Outcomes of Reperfusion Therapy in Patients with Cancer
Stroke 52:2026-2034, Yoo, J.,et al, 2021
A 7-Year-Old Boy with Acute-Onset Altered Mental Status
Neurol 96:e2774-e2778, Wong, G.J.,et al, 2021
Mechanisms of Ischemic Stroke in Patients with Cancer
Ann Neurol 90:159-169, Navi, B.B.,et al, 2021
A 79-Year-Old Woman with Subacute Bilateral Visual Loss
Neurol 97:e1159-e1165, Rossi, S.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Association of Brain Cancer with Risk of Suicide
JAMA doi:10.1001/JAMANETWORKOPEN.2020.3862, Saad, A.M.,et al, 2020
Cerebral Metastases
NEJM 382:e36, Sacks, C.A., 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
NEJM 382:1599-1607,1650, Agnelli, G.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020